Connect with us

Media OutReach

Neo Smiles Dental Studio Marks 10 Years of Orthodontic Care in Singapore

Published

on

SINGAPORE – Media OutReach Newswire – 8 August 2025 – Neo Smiles Dental Studio marks its 10th anniversary, reflecting on a decade of growth from a one-chair practice in the heartlands to a multi-branch provider of specialist orthodontic care. With clinics operating in Bedok, Serangoon, and Bishan, the practice group continues to serve students, working adults, and families through flexible appointment hours and structured treatment options designed for community accessibility.

Neo Smiles 10 year celebration

From Start-Up to Multi-Branch Practice

Neo Smiles began as a solo practice focused on delivering affordable orthodontic care to residents in the heartlands. Over time, the clinic expanded its team and facilities to meet growing demand.

Today, the clinic operates as a specialist orthodontic clinic chain in Singapore with three locations, offering a full suite of orthodontic care. The team includes three orthodontists, one oral surgeon, and several general dentists. Services range from traditional metal and ceramic braces to Damon self-ligating systems and aligner treatments such as Invisalign, as well as oral surgery procedures, including wisdom tooth removal with sedation, and routine dental care.

Neo Smiles has also been awarded the Invisalign Diamond Tier Practice, supported by in-clinic technology, dedicated orthodontic staff, and the use of iTero Lumina 3D intraoral scanners. Clinics are designed with patient comfort in mind, featuring amenities such as piped-in music, aromatherapy, and overhead televisions to create a more relaxed treatment environment.

“When we started Neo Smiles, our goal was to provide accessible specialist care without requiring patients to travel into the city,” said Dr Neo Bijuan, Clinical Director at Neo Smiles Dental Studio. “Ten years on, we remain focused on bringing structured, reliable care to neighbourhoods where it’s needed most.”

Adapting to Challenges and Expanding Access

The clinic’s 10-year journey has included significant challenges, such as staffing disruptions especially during the COVID-19 pandemic. In 2023, Neo Smiles relocated its Kovan branch to Serangoon Central due to an unexpected site closure. The move enabled the team to continue operations in a more centrally located space, allowing for greater accessibility for patients in the area.

Dental technology has progressed significantly, and Neo Smiles has incorporated digital tools into its clinical workflow. Intraoral scanners are used to generate precise 3D digital models of a patient’s teeth and gums, replacing traditional physical impressions. The clinic also employs CBCT (Cone Beam Computed Tomography) imaging, which supports detailed diagnostics and treatment planning while using lower radiation levels compared to conventional CT scans.

Patient-Centred Milestones

Over the past decade, the clinic’s photo wall has become a familiar feature, displaying Polaroid snapshots of patients who have completed their braces or Invisalign dental treatments. This visual record reflects the number of individuals who have completed their treatment plans and has become a long-standing tradition at Neo Smiles, capturing meaningful moments in their orthodontic care journeys.

The clinic continues to serve families, with parents bringing in children for early consultations and routine follow-ups. In addition to services such as braces for kids, Neo Smiles now offers a broader range of pre- and post-treatment options, including teeth whitening, stain removal, and black triangle management. The clinic also provides procedural support such as CBCT 3D X-ray imaging and sedation options for wisdom tooth surgeries, enabling continuity of care across different treatment stages.

Looking Ahead to the Next Decade

Neo Smiles continues to focus on improving access to specialist orthodontic care, especially for patients in the heartlands. To support affordability, the clinic provides student braces packages, flexible instalment options and dental financial assistance for eligible patients. The clinic is also Medisave-accredited and accepts Pioneer Generation, Merdeka Generation, and CHAS subsidies. In addition, the clinic participates in the Baby Bonus Scheme and accepts CDC, LifeSG, and SG60 vouchers.

As the clinic enters its 11th year, Neo Smiles remains focused on its founding purpose: providing accessible, structured treatment while prioritising the patient experience. Although its services and technology have expanded over the years, the team’s focus on attentive service and fostering a welcoming environment continues to shape its daily practice.

For more information or to schedule an appointment, visit www.neosmiles.com.sg or contact the clinic directly.
Hashtag: #NeoSmiles




The issuer is solely responsible for the content of this announcement.

About Neo Smiles Dental Studio

Neo Smiles Dental Studio is a Singapore-based practice specialising in orthodontic and general dental services. Since opening its first clinic in Bedok in 2014, Neo Smiles has expanded to three locations, providing treatments such as braces, Invisalign, oral surgery, and general dental care. The clinic is committed to making specialist orthodontic care accessible through evening and weekend appointments, heartland locations, and structured payment plans.

Advertisement

Media OutReach

Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in three additional markets in Asia

Published

on

SINGAPORE – Media OutReach Newswire – 12 March 2026 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to Cialis® (Tadalafil), a leading men’s health product from Eli Lilly and Company (“Lilly”) in Hong Kong, Macau and South Korea.

Following the acquisition, Zuellig Pharma will now own the trademarks, marketing authorizations and license manufacturing know-how for Cialis®, a treatment for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), in 11 markets in Asia, with the expansion of its ownership into three additional markets beyond the original eight. Zuellig Pharma will also continue to promote and distribute the brand in these markets.

The expanded ownership of Cialis® will widen accessibility of the drug to a significant population of men in Asia who are affected by ED and BPH. The acquisition also aligns with Zuellig Pharma’s strategic priority of building a strong portfolio of owned prescription healthcare products as an integrated healthcare solutions company.

“Our acquisition of Cialis® in three additional markets builds on the strong foundation we established two years ago and highlights our proven success in scaling trusted brands effectively through our commercial capabilities and deep expertise. As we broaden our footprint, we remain focused on delivering sustainable growth and advancing our purpose of making in-demand healthcare solutions more accessible to communities in Asia,” said John Graham, CEO of Zuellig Pharma.
Hashtag: #ZuelligPharma #EliLillyandCompany #Cialis #MensHealth #Healthcare #Pharmaceuticals


The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma

Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, commercialization, and clinical trial support services, underpinned by a strong culture of innovation to support the growing healthcare needs in this region. The company was founded a hundred years ago and has grown to become a multibillion-dollar business covering 18 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.

Continue Reading

Media OutReach

Ingdan Powers Embodied AI with Humanoid-Style Brain-Cerebellum Chipset to Boost Robotics Ecosystem

Published

on

HONG KONG SAR – Media OutReach Newswire – 12 March 2026 – Ingdan, Inc. (“Ingdan” or the “Company”, stock code: 400.HK; with its subsidiaries (the ”Group”)), a core supplier in the AI computing power supply chain and a leading application technology solutions provider, announces continued progress in strengthening its humanoid robotics ecosystem through an integrated embodied intelligence IC product matrix, supporting the industry’s transition toward large‑scale commercialization.

2026 is widely regarded as a milestone year for humanoid robotics, in which humanoid robots transition from laboratory prototypes and demonstration performances to large‑scale mass production. At CES in January, NVIDIA announced the commercial launch of its physical‑AI core platform Jetson Thor. Tesla is scheduled to officially release the mass‑production engineering version of its Optimus (V3) humanoid robot by the end of March, with plans to initiate million‑unit‑level production lines by the end of 2026—an inflection point widely regarded as the “Model 3 moment” of the humanoid robotics industry. At the same time, Chinese robotics companies such as AGIBOT, Unitree, and Fourier Intelligence have already deployed products at scale in warehousing and logistics scenarios.

Against this backdrop, the upstream hardware focus of the humanoid robotics industry is increasingly converging on “Brain-Cerebellum” collaboration and low‑latency, multi‑joint real‑time control, which are essential to achieving coordinated, smooth, and human‑like robotic motion. During the CMG Spring Festival Gala, robots from multiple companies demonstrated complex coordinated movements and dexterous hand operations, further highlighting the value of this technical direction.

D‑Robotics, originating from the AIoT and robotics division of Horizon Robotics, focuses on edge‑side embodied intelligence solutions characterized by high computing power, integrated computation and control, and low latency. Leveraging its parent company’s long‑term experience in intelligent driving, D‑Robotics has established a precise position in humanoid robot “Brain-Cerebellum” coordination and real‑time joint control.

In November 2025, D‑Robotics unveiled its flagship robotics computing platform S600, with an official release planned for the end of the first quarter of 2026. The S600 platform features a highly integrated humanoid‑style “Brain-Cerebellum” chipset architecture. Its “Brain” configuration combines an 18‑core A78AE CPU with a proprietary Nash‑architecture BPU, delivering 560 TOPS (INT8) edge computing power and supporting efficient deployment of VLA, VLM, LLM, and locomotion models. Its “Cerebellum” configuration integrates a 6‑core R52+ MCU, providing high‑reliability, real‑time motion control.

By integrating CPU, BPU, and real‑time MCU capabilities into a single SoC, S600 enables a closed‑loop architecture encompassing perception, decision‑making, and real‑time action control. This design addresses a key industry challenge in which many edge AI processors lack embedded real‑time MCUs and rely on external controllers, resulting in excessive latency. The integrated MCU supports high‑frequency, high‑precision PWM signal generation based on FOC algorithms, enabling precise motor control and contributing to stable rhythm and natural gait.

The S600 platform has been adopted by multiple robotics companies such as Fourier Intelligence, Booster Robotics, X Square Robot, and ROBOTERA, supporting applications that require stable multi‑joint coordination and smooth motion performance.

Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.

D‑Robotics is a core product line Ingdan distributes . Building on D‑Robotics’ products and combined with its own technical services—such as multi‑sensor fusion development, real‑time closed‑loop tuning, Quantization‑Aware Training (QAT) support, simulation testing, and modular SOM customization—the Group has supported sophisticated customers including Galbot and ROBOTERA, continuously enriching the robotics industry ecosystem.

Looking ahead, Ingdan will continue to focus on the humanoid robotics sector. Leveraging an IC product matrix centered on NVIDIA Jetson and D‑Robotics platforms, the Company aims to further strengthen its AI intelligent terminal capabilities and continue supporting the iterative development of embodied intelligence products.

For investor and media enquiries
Please email to **@****an.com

Hashtag: #Ingdan #Chips #humanoid #D‑Robotics #NVIDIA #Tech

The issuer is solely responsible for the content of this announcement.

Ingdan, Inc.

Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.

Continue Reading

Media OutReach

Snow, Ice, and Performance: 2026 Changan Global Testing Season Arrives in Europe with Back-to-Back Winter Events

Published

on

  • European dealers and journalists experienced the CHANGAN DEEPAL S05 AWD at 2026 Changan Global Testing Season this February.
  • With intelligent AWD and advanced ADAS, the CHANGAN DEEPAL S05 AWD offered uncompromising safety and control on winter roads.

Saalfelden, Austria – Media OutReach Newswire – 12 March 2026 – Following extreme cold tests in Yakeshi, China, the 2026 Changan Global Testing Season made its European debut this February with the Changan Winter Experience in Courmayeur and the Winter Test Drives in Saalfelden. The all-electric CHANGAN DEEPAL S05 AWD was tested on snow and ice—familiar conditions for European drivers—offering dealers and journalists an immersive introduction to Changan’s electric mobility vision through dynamic drives.

Three-time Olympic gold medalist and Milano Cortina 2026 Ambassador Deborah Compagnoni joined the event in Courmayeur, testing the CHANGAN DEEPAL S05 AWD. Her career—defined by determination, control, and reliability—reflects Changan’s core values. “I felt that the principles of trajectory and speed in skiing apply to driving. With this model, you gain confidence on challenging terrain,” she said.

Snow-Validated Performance: The CHANGAN DEEPAL S05 AWD

Tested in Europe, the CHANGAN DEEPAL S05 AWD demonstrated controllable dynamics, reliable traction, and enhanced safety—highlighting its cutting-edge AWD and ADAS. The system adapts seamlessly: ECO/COMFORT modes prioritize RWD efficiency, while AWD will engage automatically when sensors detect slip, high torque demand, or extreme cold below -25°C. SPORT mode delivers permanent 50:50 torque for sharper response. SNOW mode maintains balanced torque with optimized slip control for confident driving on low-grip surfaces.

The intelligent AWD system delivers up to 320 kW power, 502 Nm torque, and 0–100 km/h acceleration in 5.5 seconds. It also improves hill climbing with a 40% gradient capability, ensures stability by actively balancing power to prevent skidding, and enables safer cornering at higher speeds through optimized grip and vehicle dynamics.

Changan Standard: Proven in the Alps, Bound for the World

Changan Standard is defined by a principle: forged in extremes, built for every day. From Yakeshi to the Alps, the test environments are selected to verify specific performance attributes—safety technologies, chassis response, all-wheel-drive calibration, and ADAS in low-grip scenarios. The objective of 2026 Global Testing Season is not to demonstrate extremes, but to confirm consistency: that the same level of safety, control, and stability demonstrated will be replicated in Mexico, Thailand, and Saudi Arabia.

Hashtag: #Changan

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending